The Journal of Immunology, Vol 155, Issue 10 4805-4816, Copyright © 1995 by American Association of Immunologists

ARTICLES

Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth

WC Lin, S Yasumura, Y Suminami, MW Sung, S Nagashima, J Stanson and TL Whiteside
Department of Pathology, University of Pittsburgh School of Medicine, PA, USA.

Human carcinomas spontaneously express abundant IL-2R beta but little IL-2R alpha on the cell surface, contain mRNA for IL-2R beta- and IL-2R alpha-chains, and may be inhibited in growth by exogenous IL-2. To study the relationship between IL-2R expression and growth inhibition by IL-2, carcinoma cells were transduced with IL-2R alpha and IL-2R gamma cDNAs or IL-2R beta antisense cDNA. Transfectants with the IL-2R alpha gene expressed high levels of the alpha- and beta-receptor chains and showed increased binding of [125I]IL-2. Exogenous IL-2 at the picometer concentrations inhibited their growth, and Abs to IL-2R alpha- or IL-2R beta-chains reversed the inhibition. After transduction of IL- 2R beta antisense cDNA, gastric carcinoma (HR) cells no longer expressed IL-2R beta-chain, and their proliferation was depressed in the absence of exogenous IL-2. Transduction of IL-2R gamma-chain cDNA into tumor cells increased sensitivity to growth inhibition by exogenous IL-2 of a squamous cell carcinoma line, but not of HR or renal cell carcinoma lines. All of the parental and transduced tumor cell lines were found to constitutively express intracellular IL-2, detectable by immunostaining or flow cytometry of permeabilized cells. IL-2 was present on the surface of some tumor cells. Intracellular IL- 2R beta and IL-2R gamma proteins were also detectable in tumor cells. Using reverse-transcription PCR combined with Southern blots or in situ hybridization, mRNA for IL-2 was found to be present in parental and transduced tumor cells. Expression on human carcinomas of IL-2R beta, inhibition of their growth by IL-2R beta antisense cDNA, and their ability to constitutively produce IL-2 and its presence on the cell surface, all suggest that endogenous IL-2 may play a role in tumor cell growth.

This article has been cited by other articles:

				C. Quan and S.-J. Lu Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays Carcinogenesis, October 1, 2003; 24(10): 1593 - 1599. [Abstract] [Full Text] [PDF]

				L.-S. Wang, K.-C. Chow, W.-Y. Li, C.-C. Liu, Y.-C. Wu, and M.-H. Huang Clinical Significance of Serum Soluble Interleukin 2 Receptor-{{alpha}} in Esophageal Squamous Cell Carcinoma Clin. Cancer Res., April 1, 2000; 6(4): 1445 - 1451. [Abstract] [Full Text]

				H.-F. Chen, E.-B. Jeung, M. Stephenson, and P. C. K. Leung Human Peripheral Blood Mononuclear Cells Express Gonadotropin-Releasing Hormone (GnRH), GnRH Receptor, and Interleukin-2 Receptor {gamma}-Chain Messenger Ribonucleic Acids That Are Regulated by GnRH in Vitro J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 743 - 750. [Abstract] [Full Text]

				S. Nagashima, R. Mailliard, Y. Kashii, T. E. Reichert, R. B. Herberman, P. Robbins, and T. L. Whiteside Stable Transduction of the Interleukin-2 Gene Into Human Natural Killer Cell Lines and Their Phenotypic and Functional Characterization In Vitro and In Vivo Blood, May 15, 1998; 91(10): 3850 - 3861. [Abstract] [Full Text] [PDF]

				T. E. Reichert, S. Watkins, J. Stanson, J. T. Johnson, and T. L. Whiteside Endogenous IL-2 in Cancer Cells: A Marker of Cellular Proliferation J. Histochem. Cytochem., May 1, 1998; 46(5): 603 - 612. [Abstract] [Full Text]